Pancreatic Cancer Research

ResearcherHarbin Medical UniversityNo recent work listed

Lin Fang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0000-3249-4322; OpenAlex author ID A5103983625. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2019: 1 paper · 2020: 3 papers · 2021: 1 paper · 2022: 1 paper

Papers 6

  1. HOXB9 blocks cell cycle progression to inhibit pancreatic cancer cell proliferation through the DNMT1/RBL2/c-Myc axis. Co-author DOI 10.1016/j.canlet.2022.215595↗
  2. Systemic Inflammatory Biomarkers, Especially Fibrinogen to Albumin Ratio, Predict Prognosis in Patients with Pancreatic Cancer. Co-author DOI 10.4143/crt.2020.330↗
  3. Lower Mean Corpuscular Hemoglobin Concentration is Associated with Favorable Prognosis of Resected Pancreatic Cancer. Co-author DOI 10.21203/rs.3.rs-109365/v1↗
  4. Preoperative Mean Corpuscular Hemoglobin Concentration, Red Cell Distribution Width As Predictive Markers For Pancreatic Cancer Patients Who Underwent Radical … Co-author DOI 10.21203/rs.3.rs-37763/v1↗
  5. Ubiquitin specific peptidase 5 enhances STAT3 signaling and promotes migration and invasion in Pancreatic Cancer. Co-author DOI 10.7150/jca.48536↗
  6. STAT1-mediated inhibition of FOXM1 enhances gemcitabine sensitivity in pancreatic cancer. Co-author DOI 10.1042/cs20180816↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yanqiao Zhang · 4 shared papers, 2019–2022 · strength 0.43
  2. Changjie Lou · 3 shared papers, 2019–2022 · strength 0.31
  3. Jie Lian · 3 shared papers, 2019–2021 · strength 0.30
  4. Yang Yao · 2 shared papers, 2021–2022 · strength 0.24
  5. Xiaona Fan · 2 shared papers, 2020 · strength 0.22
  6. Zhiwei Li · 2 shared papers, 2020 · strength 0.22
  7. Dan Wang · 2 shared papers, 2020–2021 · strength 0.22
  8. Zhiwei Li · 2 shared papers, 2019–2021 · strength 0.19
  9. Hengzhen Li · 1 shared paper, 2022 · strength 0.13
  10. Chao Liu · 1 shared paper, 2020 · strength 0.11
  11. Dan Su · 1 shared paper, 2020 · strength 0.11
  12. Dan Wang · 1 shared paper, 2020 · strength 0.11
  13. Chao Liu · 1 shared paper, 2019 · strength 0.08
  14. Qi Zhao · 1 shared paper, 2019 · strength 0.08
  15. Jiaqi Shi · 1 shared paper, 2019 · strength 0.08
  16. Zengxun Li · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.